Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco (Q44357361)
Jump to navigation
Jump to search
scientific article published on 8 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco |
scientific article published on 8 November 2013 |
Statements
1 reference
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco (English)
1 reference
I Ray-Coquard
H Gelderblom
B M Seddon
S Sleijfer
J M Kerst
S Bauer
M Ouali
S Marreaud
R J H M van der Straaten
S D Weitman
8 November 2013
1 reference